• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

并且其代谢产物硫化氢会改变肠道微生物群落组成和自噬过程，促进结直肠癌的进展。

and its metabolite hydrogen sulfide alter gut microbiota composition and autophagy process and promote colorectal cancer progression.

机构信息

Department of Pharmaceutical Microbiology, School of Life Science and Technology, China Pharmaceutical University , Nanjing, China.

State Key Laboratory of Natural Medicines, China Pharmaceutical University , Nanjing, China.

出版信息

Microbiol Spectr. 2023 Dec 12;11(6):e0229223. doi: 10.1128/spectrum.02292-23. Epub 2023 Oct 27.

DOI:10.1128/spectrum.02292-23
PMID:37889013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10714730/
Abstract

Colorectal cancer (CRC) is the second most common cancer in the world; the main treatment for CRC is immunosuppressive therapy, but this therapy is only effective for a small percentage of CRC patients, so there is an urgent need for a treatment with fewer side effects and higher efficacy. This study demonstrated that with increased abundance in CRC can regulate the autophagy process and disrupt normal intestinal microbiota by producing hydrogen sulfide, factors that may be involved in the development and progression of CRC. This study may provide a reference for future CRC treatment options that are efficient and have fewer side effects.

摘要

结直肠癌（CRC）是世界上第二常见的癌症；CRC 的主要治疗方法是免疫抑制疗法，但这种疗法仅对一小部分 CRC 患者有效，因此迫切需要一种副作用更少、疗效更高的治疗方法。本研究表明，在 CRC 中丰度增加可以通过产生硫化氢来调节自噬过程并破坏正常的肠道微生物群，这些因素可能参与 CRC 的发展和进展。本研究可能为未来高效低副作用的 CRC 治疗方案提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/40220998e85d/spectrum.02292-23.f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/72fb247d8905/spectrum.02292-23.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/41c7bb0c5f01/spectrum.02292-23.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/59b6d8a14380/spectrum.02292-23.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/7082c7923bbe/spectrum.02292-23.f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/b4549811dcc9/spectrum.02292-23.f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/93db2561cbb3/spectrum.02292-23.f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/3de85b40c9a4/spectrum.02292-23.f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/40220998e85d/spectrum.02292-23.f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/72fb247d8905/spectrum.02292-23.f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/41c7bb0c5f01/spectrum.02292-23.f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/59b6d8a14380/spectrum.02292-23.f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/7082c7923bbe/spectrum.02292-23.f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/b4549811dcc9/spectrum.02292-23.f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/93db2561cbb3/spectrum.02292-23.f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/3de85b40c9a4/spectrum.02292-23.f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/993e/10714730/40220998e85d/spectrum.02292-23.f008.jpg

相似文献

1
and its metabolite hydrogen sulfide alter gut microbiota composition and autophagy process and promote colorectal cancer progression.并且其代谢产物硫化氢会改变肠道微生物群落组成和自噬过程，促进结直肠癌的进展。
Microbiol Spectr. 2023 Dec 12;11(6):e0229223. doi: 10.1128/spectrum.02292-23. Epub 2023 Oct 27.
2
Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.二甲双胍通过调节肠道微生物群发挥抗肿瘤作用，并挽救具核梭杆菌诱导的结直肠肿瘤发生。
EBioMedicine. 2020 Nov;61:103037. doi: 10.1016/j.ebiom.2020.103037. Epub 2020 Oct 9.
3
promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota.促进结直肠癌肝转移，通过调节肝脏免疫微环境和改变肠道微生物群。
Aging (Albany NY). 2022 Feb 25;14(4):1941-1958. doi: 10.18632/aging.203914.
4
-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer.微生物组衍生的丁酸水平失衡促进结直肠癌的发生和发展。
World J Gastroenterol. 2024 Apr 14;30(14):2018-2037. doi: 10.3748/wjg.v30.i14.2018.
5
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.具核梭杆菌通过调节自噬促进结直肠癌的化学抗性。
Cell. 2017 Jul 27;170(3):548-563.e16. doi: 10.1016/j.cell.2017.07.008.
6
Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism.具核梭杆菌与结直肠癌：从现象到机制。
Front Cell Infect Microbiol. 2022 Nov 29;12:1020583. doi: 10.3389/fcimb.2022.1020583. eCollection 2022.
7
Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.CRC 进展中的微生物动态：在癌症、腺瘤性息肉和健康对照的多个部位的黏膜微生物组中进行的研究。
Eur J Clin Microbiol Infect Dis. 2023 Mar;42(3):305-322. doi: 10.1007/s10096-023-04551-7. Epub 2023 Jan 27.
8
induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway.通过抑制 Hippo 通路中的细胞焦亡来诱导结直肠癌细胞的化疗耐药性。
Gut Microbes. 2024 Jan-Dec;16(1):2333790. doi: 10.1080/19490976.2024.2333790. Epub 2024 Mar 27.
9
Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.具核梭杆菌通过改变小鼠模型的黏膜微生物群和结肠转录组促进结直肠癌的进展。
World J Gastroenterol. 2022 May 14;28(18):1981-1995. doi: 10.3748/wjg.v28.i18.1981.
10
Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.具核梭杆菌通过上调结直肠癌中 BIRC3 的表达促进氟尿嘧啶的化疗耐药性。
J Exp Clin Cancer Res. 2019 Jan 10;38(1):14. doi: 10.1186/s13046-018-0985-y.

引用本文的文献

1
Anaerobic gut bacteria and their potential role in the initiation, exacerbation, and development of human colorectal cancer: a narrative review.厌氧肠道细菌及其在人类结直肠癌的起始、恶化和发展中的潜在作用：一篇叙述性综述。
Front Cell Infect Microbiol. 2025 Jul 25;15:1559001. doi: 10.3389/fcimb.2025.1559001. eCollection 2025.
2
Microbiota-driven epigenetic modifications in gastrointestinal cancer: Implications for pathogenesis and therapeutic strategies.微生物群驱动的胃肠道癌表观遗传修饰：对发病机制和治疗策略的影响
World J Microbiol Biotechnol. 2025 Jul 28;41(8):288. doi: 10.1007/s11274-025-04457-w.
3
Diagnostic value of methane-hydrogen breath test combined with intestinal flora testing in screening for colorectal polyps.
甲烷-氢气呼气试验联合肠道菌群检测在结直肠息肉筛查中的诊断价值
Front Med (Lausanne). 2025 May 30;12:1530558. doi: 10.3389/fmed.2025.1530558. eCollection 2025.
4
Deciphering microbial and metabolic influences in gastrointestinal diseases-unveiling their roles in gastric cancer, colorectal cancer, and inflammatory bowel disease.解读胃肠道疾病中的微生物和代谢影响——揭示它们在胃癌、结直肠癌和炎症性肠病中的作用。
J Transl Med. 2025 May 16;23(1):549. doi: 10.1186/s12967-025-06552-w.
5
Gut microbiota - bidirectional modulator: role in inflammatory bowel disease and colorectal cancer.肠道微生物群——双向调节因子：在炎症性肠病和结直肠癌中的作用
Front Immunol. 2025 Apr 30;16:1523584. doi: 10.3389/fimmu.2025.1523584. eCollection 2025.
6
Innovative strategies targeting oral microbial dysbiosis: unraveling mechanisms and advancing therapies for periodontitis.针对口腔微生物群落失调的创新策略：揭示牙周炎的发病机制并推进其治疗方法
Front Cell Infect Microbiol. 2025 Apr 30;15:1556688. doi: 10.3389/fcimb.2025.1556688. eCollection 2025.
7
Gut microbiota-mitochondrial crosstalk in obesity: novel mechanistic insights and therapeutic strategies with traditional Chinese medicine.肥胖中肠道微生物群与线粒体的相互作用：基于中药的新机制见解与治疗策略
Front Pharmacol. 2025 Apr 22;16:1574887. doi: 10.3389/fphar.2025.1574887. eCollection 2025.
8
Helicobacter pylori, microbiota and gastric cancer - principles of microorganism-driven carcinogenesis.幽门螺杆菌、微生物群与胃癌——微生物驱动致癌作用的原理
Nat Rev Gastroenterol Hepatol. 2025 May;22(5):296-313. doi: 10.1038/s41575-025-01042-2. Epub 2025 Feb 26.
9
Interplay of m6A RNA methylation and gut microbiota in modulating gut injury.m6A RNA甲基化与肠道微生物群在调节肠道损伤中的相互作用。
Gut Microbes. 2025 Dec;17(1):2467213. doi: 10.1080/19490976.2025.2467213. Epub 2025 Feb 17.
10
Dysregulated genes in HIGK-treated and their possible association with HNSCC.HIGK处理后失调的基因及其与头颈部鳞状细胞癌的可能关联。
Mol Biol Res Commun. 2025;14(1):59-71. doi: 10.22099/mbrc.2024.50171.1982.